LCM
IOBT

Landscape Capital Management’s IO Biotech IOBT Stock Holding History

Landscape Capital Management’s Portfolio IOBT Stock Details IOBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-347,408
Closed -$483K – 714
2025
Q2 		$483K Sell
347,408
-52,826
-13% -$60.5K 0.04% 458
2025
Q1 		$436K Sell
400,234
-41,962
-9% -$39.6K 0.04% 433
2024
Q4 		$407K Buy
+442,196
New +$440K 0.04% 456

Other funds holding IOBT

NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Landscape Capital Management's IOBT Position: Q3 2025 in Review

Landscape Capital Management sold out of IO Biotech (IOBT) in Q3 2025, closing a stake of 347,408 shares — an estimated $483K sold.

Landscape Capital Management first reported a position in IOBT in Q4 2024 and held it in 3 quarters. The position peaked at $483K in Q2 2025. 21 funds tracked by Wall St. Rank hold IOBT as of Q3 2025.

  • Landscape Capital Management reported no remaining IO Biotech position as of Q3 2025 after selling out during the quarter.
  • Landscape Capital Management sold 347,408 IO Biotech shares in Q3 2025, an estimated $483K.
  • Landscape Capital Management first reported a position in IO Biotech in Q4 2024 and held it in 3 quarters.
  • Landscape Capital Management's IO Biotech position peaked at $483K in Q2 2025.
  • 21 funds tracked by Wall St. Rank held IO Biotech as of Q3 2025.

Based on Landscape Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.